As a transdermal penetration system, the Convoy Therapeutics technology offers a unique delivery option due to its "plug and play" capability. This allows the company to readily reformulate existing molecules (approved and otherwise) increasing skin penetration by orders of magnitude compared to competing technologies. This reduces time to market and improves the patient experience, decreasing dosing regimens and increasing patient compliance.
